Received by email:
File: PR Passing of Harry Miller v6.docx
VANITY CAPITAL INC. REPORTS ON THE PASSING OF HARRY MILLER, C.E.O. AND DIRECTOR
Vancouver, British Columbia, April 2, 2019 - Vanity Capital Inc. (TSXV: VYC) (the "Company" or "Vanity") reports with
--->sadness that Harry Miller, the CEO and director of the Company, passed away last week. The board has appointed Nichola
--->s Segounis as Chief Executive Officer.
Harry was born in Vancouver, British Columbia. He went to King Edward Elementary school where he formed life-long frie
--->ndships. Harry obtained his Bachelor of Commerce in Manufacturing at the University of British Columbia in 1957, and h
--->e worked in several different industries which eventually led him to a career in the stock market. Harry was instrumen
--->tal during his career in listing and raising capital for companies on the TSX Venture Exchange, TSX, NASDAQ, AMEX and
--->NYSE. He had a love of learning, passion for collaborating, and a track record of building companies that were success
--->ful. His entrepreneurial spirit and business acumen created value and a loyal shareholder base.
Harry built deep and lasting relationships and had a way of making people feel as if they had been heard and that they
---> mattered. His connections with others was real, genuine and long lasting. A promise made is a promise kept was a trad
--->e mark of Harry's, and he displayed this quality in his business and personal life. He was the quintessential people
Nicholas Segounis, CEO and President commented "Harry was one in a million. His word was his bond, and he led his life
---> in the public markets with integrity, commitment and concern for what was best for his shareholders. Vanity was very
--->fortunate to have his leadership and the benefit of his influence. I personally was honored to work with him and to ha
--->ve had his friendship over the years."
Harry was working toward a reverse-merger transaction (the "Transaction") with XynaRx Pharmaceuticals Corp. ("XynaRx")
--->. He was very excited about the future of Vanity and the potential value XynaRx would bring to shareholders. The board
---> is committed to Harry's vision and fulfilling the mandate received from Vanity shareholders at the special meeting he
--->ld on March 21, 2019 to complete the XynaRx business combination.
The board extends its deepest condolences to Harry's wife of 42 years Carol Miller, the Miller family, and Harry's man
--->y friends. He will be truly missed.
Vanity is currently a TSXV listed junior exploration company. Vanity staked 69 claims in February 2017, covering appro
--->ximately 1,000 acres in the Phillips Township, Kenora District, Ontario (the "Phillips Property"). Vanity is pursuing
--->a strategic alternative to enhance shareholder value through the arm's length business Transaction with XynaRx.
XynaRx is a privately held British Columbia incorporated company focused on incorporating cannabidiol ("CBD") in over
--->the counter ("OTC") healthcare products and generic medications. XynaRx intends to manufacture in-house and distribute
---> its products in global markets. Management of XynaRx has developed a pipeline to introduce 15 OTC products and generi
--->c medications with CBD as an active ingredient (the "XynaRx Products") over the next five years. Research and developm
--->ent will be conducted in-house for incorporating CBD in the 15 XynaRx Products and for conducting human trials.
The shares of Vanity are currently halted from trading, and the trading of shares of Vanity is expected to remain halt
--->ed until delisted from the TSXV and completion of the proposed transaction with XynaRx or its termination. There can b
--->e no assurance that the proposed transaction, as previously announced on March 14, 2019, will be completed as proposed
---> or at all.
For further information, contact:
Nicholas Segounis CEO and President (604) 649-6916
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE
--->TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities
--->legislation. Such forward-looking information is not representative of historical facts or information or current cond
--->itions, but instead represents only the Company's beliefs regarding future events, plans or objectives, many of which,
---> by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking infor
--->mation can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "i
--->s expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "b
--->elieves", or variations of such words and phrases or may contain statements that certain actions, events or results "m
--->ay", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-lo
--->oking information contained herein may include, but is not limited to, information concerning the Transaction, expecta
--->tions regarding whether the Transaction will be consummated, including whether conditions to the consummation of the T
--->ransaction will be satisfied, delisting from the TSXV, the timing for completing the Transaction, expectations for the
---> effects of the Transaction or the ability of the resulting issuer of the Transaction to successfully achieve its busi
--->ness objectives, and expectations for other economic, business, and/or competitive factors.
By identifying such information in this manner, the Company is alerting the reader that such information is subject to
---> known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, perfor
--->mance or achievements of the Company to be materially different from those expressed or implied by such information. I
--->n addition, in connection with the forward-looking information contained in this news release, the Company has made ce
--->rtain assumptions. Among the key factors that could cause actual results to differ materially from those projected in
--->the forward-looking information is the following: the ability to consummate the Transaction; the ability to delist fro
--->m the TSXV; the ability to obtain requisite regulatory and securityholder approvals and the satisfaction of other cond
--->itions to the consummation of the Transaction on the proposed terms and schedule; the ability to satisfy the condition
--->s to the Transaction; the potential impact of the announcement or consummation of the Transaction on relationships, in
--->cluding with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business
---> and political conditions, including changes in the financial markets; changes in applicable laws; compliance with ext
--->ensive government regulation; and the diversion of management time on the Transaction. Should one or more of these ris
--->ks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or st
--->atements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticip
--->ated, believed, estimated or expected.
Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, t
--->he forward-looking information is reasonable, undue reliance should not be placed on such information, and no assuranc
--->e or guarantee can be given that such forward-looking information will prove to be accurate, as actual results and fut
--->ure events could differ materially from those anticipated in such information. The forward-looking information contain
--->ed in this news release is made as of the date of this news release, and the Company does not undertake to update any
--->forward-looking information that is contained or referenced herein, except in accordance with applicable securities la
--->ws. All subsequent written and oral forward-looking information attributable to the Company or persons acting on its b
--->ehalf is expressly qualified in its entirety by this notice.
© 2022 Canjex Publishing Ltd. All rights reserved.